Retraction Note: Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway

Stem Cell Res Ther. 2023 Sep 29;14(1):280. doi: 10.1186/s13287-023-03474-6.

Yun Feng^#^{1

2

3}, Linlin Wang^#^{1

4}, Xiaoying Ma⁵, Xiaotong Yang⁵, Ocholi Don², Xiaoyan Chen⁶, Jieming Qu^{7

8}, Yuanlin Song^{9

10

11

12}

¹ Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 20003, China.
² Department of Respiration, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
³ Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
⁴ Shanghai Respiratory Research Institute, Shanghai, 20003, China.
⁵ State Key Laboratory of Bioreactor Engineering & Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, People's Republic of China.
⁶ Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China.
⁷ Department of Respiration, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China. jmqu0906@163.com.
⁸ Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai, 20025, China. jmqu0906@163.com.
⁹ Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 20003, China. ylsong70@163.com.
¹⁰ Shanghai Respiratory Research Institute, Shanghai, 20003, China. ylsong70@163.com.
¹¹ Department of Pulmonary Medicine, Zhongshan Hospital, Qingpu Branch, Fudan University, Shanghai, 201700, China. ylsong70@163.com.
¹² National Clinical Research Center for Aging & Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. ylsong70@163.com.

^# Contributed equally.

No abstract available

Publication types